ClinicalTrials.Veeva

Menu

Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #1

Taisho Pharmaceutical logo

Taisho Pharmaceutical

Status

Completed

Conditions

Healthy Participants

Treatments

Other: Harsh-braking test
Other: Car-following test
Other: Road-tracking test

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT03278080
JapicCTI-173714 (Other Identifier)
DS-204-01

Details and patient eligibility

About

The purpose of this study is to set an optimal measurement time for assessing driving ability in a driving simulator in healthy volunteers.

Enrollment

20 patients

Sex

Male

Ages

21 to 64 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Body mass index (BMI) ≥18.5 and <25.0 kg/m2 at screening inspection
  • No visual impairment (enable to correct the vision with eyeglasses or contact lens)
  • Receive a prior explanation on the study, able to accept its content, and capable to provide voluntary written consent for participation in this study

Exclusion criteria

  • History of drug and food allergy
  • Routinely drink alcohol before bedtime
  • Inappropriate for enrollment in this study was judged by principal investigator or subinvestigator

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

driving test
Other group
Treatment:
Other: Car-following test
Other: Road-tracking test
Other: Harsh-braking test

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems